Related Experiment Video
Updated: Aug 4, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
[Advances in basic and clinical research on hepatocellular carcinoma in 2016]
1Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226001, China.
Hepatocellular carcinoma (HCC) research in 2016 focused on early diagnosis using molecular markers and effective treatments like targeted therapy and minimally invasive surgery. Advances aim to improve outcomes for this common cancer.
Area of Science:
- Hepatology
- Oncology
- Surgical Innovation
Background:
- Hepatocellular carcinoma (HCC) presents a significant global health challenge with rising incidence and mortality.
- Effective early diagnosis and treatment strategies for HCC are critically needed.
Purpose of the Study:
- To review research advancements in early, specific diagnosis of HCC.
- To highlight effective therapeutic strategies for HCC reported in 2016.
Main Methods:
- Review of 2016 research on molecular markers for HCC diagnosis.
- Analysis of studies on targeted therapy for HCC.
- Examination of therapeutic regimens, including robot-assisted liver resection and no-touch radiofrequency ablation.
Main Results:
- Identification of novel molecular markers for early HCC detection.
- Progress in targeted therapy demonstrating potential efficacy.
- Advancements in surgical techniques offering less invasive options for HCC treatment.
Conclusions:
- Continued research is vital for improving early diagnosis of Hepatocellular carcinoma.
- Targeted therapies and innovative surgical approaches show promise for effective HCC management.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021